These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26274617)

  • 1. Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis.
    Goldraich LA; Stehlik J; Kucheryavaya AY; Edwards LB; Ross HJ
    Am J Transplant; 2016 Jan; 16(1):301-9. PubMed ID: 26274617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation.
    Conway J; Manlhiot C; Kirk R; Edwards LB; McCrindle BW; Dipchand AI
    J Heart Lung Transplant; 2014 Mar; 33(3):241-51. PubMed ID: 24462559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, risk factors, and outcomes of lung retransplantation: An analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant Registry.
    Harhay MO; Cherikh WS; Toll AE; Christie JD; Stehlik J; Chambers D; Hayes D; Cantu E
    J Heart Lung Transplant; 2022 Oct; 41(10):1478-1486. PubMed ID: 35933297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study.
    Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E
    J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Risk Factors for Heart-Lung Transplant Recipient Outcome: An Analysis of the United Network for Organ Sharing Database.
    Shudo Y; Wang H; Lingala B; He H; Kim FY; Hiesinger W; Lee AM; Boyd JH; Currie M; Woo YJ
    Circulation; 2019 Oct; 140(15):1261-1272. PubMed ID: 31589491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Srivastava R; Keck BM; Bennett LE; Hosenpud JD
    Transplantation; 2000 Aug; 70(4):606-12. PubMed ID: 10972218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry.
    Khush KK; Kubo JT; Desai M
    J Heart Lung Transplant; 2012 May; 31(5):459-66. PubMed ID: 22418079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival, graft function, and incidence of allograft vasculopathy in heart transplant patients receiving adverse risk profile donor hearts.
    Berg K; Clemmensen TS; Tram EM; Koefoed-Nielsen P; Ilkjaer LB; Poulsen SH; Eiskjaer H
    Clin Transplant; 2018 Aug; 32(8):e13343. PubMed ID: 29974979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential outcomes with early and late repeat transplantation in the era of the lung allocation score.
    Osho AA; Castleberry AW; Snyder LD; Palmer SM; Ganapathi AM; Hirji SA; Lin SS; Davis RD; Hartwig MG
    Ann Thorac Surg; 2014 Dec; 98(6):1914-20; discussion 1920-1. PubMed ID: 25442999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database.
    Belli E; Leoni Moreno JC; Hosenpud J; Rawal B; Landolfo K
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1972-7, 1977.e1. PubMed ID: 24636155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States.
    Shahandeh N; Kim JS; Klomhaus AM; Tehrani DM; Hsu JJ; Nsair A; Khush KK; Fearon WF; Parikh RV
    J Heart Lung Transplant; 2024 Oct; 43(10):1737-1746. PubMed ID: 38950666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving risk of sudden cardiac death after heart transplant. An analysis of the ISHLT Thoracic Transplant Registry.
    Alba AC; Fan CS; Manlhiot C; Dipchand AI; Stehlik J; Ross HJ
    Clin Transplant; 2019 Mar; 33(3):e13490. PubMed ID: 30697805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods.
    Kransdorf EP; Loghmanpour NA; Kanwar MK; Temkit MH; Stehlik J
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive outcomes after lung retransplantation: A single-center review.
    Halloran K; Aversa M; Tinckam K; Martinu T; Binnie M; Chaparro C; Chow CW; Waddell T; McRae K; Pierre A; de Perrot M; Yasufuku K; Cypel M; Keshavjee S; Singer LG
    Clin Transplant; 2018 Jun; 32(6):e13281. PubMed ID: 29754418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
    Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
    JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study.
    Radovancevic B; McGiffin DC; Kobashigawa JA; Cintron GB; Mullen GM; Pitts DE; O'Donnell J; Thomas C; Bourge RC; Naftel DC
    J Heart Lung Transplant; 2003 Aug; 22(8):862-8. PubMed ID: 12909465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Decades of Lung Retransplantation: A Single-Center Experience.
    Hall DJ; Belli EV; Gregg JA; Salgado JC; Baz MA; Staples ED; Beaver TM; Machuca TN
    Ann Thorac Surg; 2017 Apr; 103(4):1076-1083. PubMed ID: 28017335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
    Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
    Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.